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LETTERS TO THE EDITOR
Lung cancer and passive smoking
Sir-Darby and Pike (1988; 58, 825) use a multistage model
together with data on smoking and lung cancer to estimate
the effect of exposure to other people's smoke on the risk of
lung cancer. They give examples of the expected risks accord-
ing to levels of passive smoking, expressed in terms of the
number of equivalent cigarettes per day actively smoked.
In our review of the epidemiological studies of lung cancer
and exposure to other people's tobacco smoke, we estimated
that the risk of lung cancer among non-smokers living with
smokers was about 50% higher than the risk in non-exposed
non-smokers (Wald et al., 1986). This risk, according to
Darby and Pike, is approximately equivalent to smoking 0.5
cigarettes a day from birth to age 65 years, and they con-
clude it is some 5-17 times too high in the light of the level
of biochemical markers of tobacco smoke exposure that have
been measured in non-smokers. We did not think that this
was so in our review and we are still of the opinion that the
biochemical data are broadly in line with the estimates of
risk based on epidemiological studies.
In our study of the principal marker, urinary cotinine
(Wald et al., 1984; Wald & Ritchie, 1984), the mean level in
non-smokers who lived with smokers was about 1.5% (cited
in Wald et al., 1986; US National Academy of Science's
Committee on Passive Smoking, 1986; Barlow & Wald, 1988)
of the mean level found in active smokers, equivalent to
smoking about 0.3 of a cigarette per day if active cigarette
smokers typically smoke 20 cigarettes a day (1.5% of 20). An
exposure equivalent to smoking 0.3 of a cigarette a day is
similar to the estimate of 0.5 of a cigarette that would,
according to the model adopted by Darby and Pike, 'explain'
a 50% higher risk of having lung cancer in passive smokers.
The half-life of serum cotinine in non-smokers may be about
50% greater than in smokers and, if this were the case, our
estimate would become 0.2 instead of 0.3.
The principal reason for the difference in the estimates of
Darby and Pike and our own arises from their use ofdata on
urinary cotinine levels in passive smokers showing levels of
0.6-0.8% of active smokers (Jarvis et al., 1984). We believe
that the figure of 1.5% is more appropriate than that of
Jarvis and his colleagues because they did not classify co-
tinine levels by the smoking habit of the person the subject
lived with, which is needed when comparing the results with
similar epidemiological data. They also excluded self-reported
non-smokers with plasma cotinine levels greater than
20 ng ml ', which is likely to have excluded some individuals
who, while not smokers themselves, were nonetheless heavily
exposed to environmental tobacco smoke.
Bearing in mind the recognised uncertainties and diffi-
culties involved in extrapolating from the biochemical data to
the epidemiological data, there does not seem to be an
obvious discrepancy between the two.
Yours etc.
Nicholas Wald, Kiran Nanchahal & Howard Cuckle
Department of Environmental and Preventive Medicine,
St Bartholomew's Hospital Medical College,
Charterhouse Square, London ECIM 6BQ, UK;
& Simon Thompson,
Department of Clinical Epidemiology
and General Practice,
Royal Free Hospital School of Medicine,
Rowland Hill Street, London NW3 2PF, UK.
References
BARLOW, R.D. & WALD, N.J. (1988). Use of urinary cotinine to
estimate exposure to tobacco smoke. JAMA, 259, 1808.
JARVIS, M., TUNSTALL-PEDOE, H., FEYERABEND, C., VESEY, C. &
SALLOOJEE, Y. (1984). Biochemical markers of smoke absorption
and self reported exposure to passive smoking. J Epidemiol.
Comm. Health, 38, 335.
NATIONAL RESEARCH COUNCIL (1986). Environmental Tobacco
Smoke. Measuring Exposures and Assessing Health Effects.
National Academy Press: Washington, DC.
WALD, N.J., BOREHAM, J., BAILEY, A., RITCHIE, C., HADDOW, J.E.
& KNIGHT, G. (1984). Urinary cotinine as marker of breathing
other people's tobacco smoke. Lancet, i, 230.
WALD, N.J., NANCHAHAL, K., THOMPSON, S.G. & CUCKLE, H.S.
(1986). Does breathing other people's tobacco smoke cause lung
cancer? Br. Med. J., 293, 1217.
WALD, N.J. & RITCHIE, C. (1984). Validation of studies on lung
cancer in non-smokers married to smokers. Lancet, i, 1067.
Response to the letter from Dr. Wald
Sir-Wald and his colleagues question the conclusion we
reached in our recent paper that there is a discrepancy
between the low levels of exposure indicated by cotinine
measurements in those passively exposed to cigarette smoke
and the high relative risk for lung cancer of 1.5 from passive
smoke exposure estimated by Wald et al. (1986) from epi-
demiological studies.
As noted by Wald and his colleagues, an important reason
for the difference in our estimates is that we considered the
urinary cotinine levels of passive smokers to be 0.6-0.8%
that of active smokers, whereas they considered a figure of
1.5% to be more appropriate. Our figures were derived from
Tables I and II of Jarvis et al. (1984). These data compared
27 non-smokers reporting 'some' or 'a lot' (there was no
difference in the data from these two groups) of exposure to
passive smoke to 94 smokers. The mean urinary cotinine for
these 27 non-smokers reporting passive smoking exposure
was 8.8 ngml-' while that for the smokers was 1,391.0, so
that the ratio is 0.63% (8.8/1,391.0). A slightly higher figure
is obtained if plasma and salivary values are considered, and
for this reason we gave a range of 0.6-0.8%. In addition to
these 27 non-smokers, there were 79 non-smokers with 'none'
or 'a little' exposure to passive smoke, and 21 persons claim-
ing to be non-smokers but whose level of plasma cotinine
was according to the authors incompatible with their claim.
Only one of the 100 accepted non-smokers (mean plasma
cotinine, 1.5 ng ml 1) had a plasma cotinine value above
lOng ml-' (actual value 14 ng ml'), whereas all the 21
'deceivers' had values above 20 ng ml-' with a mean value of
239.3, which was 87% of the mean value for the declared
smokers. Excluding those deceivers seems completely justified
to us.
Taking, as do Wald and his colleagues, our high figure of
20 cigarettes per day consumption for smokers, and allowing
a factor of 2/3 to account for the different half-life of co-
tinine in smokers and non-smokers, the cigarette equivalent
exposure of passive smokers is estimated to be 2/3 x 0.63%
of 20 cigarettes per day or 0.08, which is still only one-sixth